Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behaviour, Department of Neurology, Nijmegen, the Netherlands.
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
JAMA. 2019 Jun 4;321(21):2113-2123. doi: 10.1001/jama.2019.6560.
Stroke remains the second leading cause of death worldwide. Approximately 10% to 15% of all strokes occur in young adults. Information on prognosis and mortality specifically in young adults is limited.
To determine short- and long-term mortality risk after stroke in young adults, according to age, sex, and stroke subtype; time trends in mortality; and causes of death.
DESIGN, SETTING, AND PARTICIPANTS: Registry- and population-based study in the Netherlands of 15 527 patients aged 18 to 49 years with first stroke between 1998 and 2010, and follow-up until January 1, 2017. Patients and outcomes were identified through linkage of the national Hospital Discharge Registry, national Cause of Death Registry, and the Dutch Population Register.
First stroke occurring at age 18 to 49 years, documented using International Classification of Diseases, Ninth Revision, and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, codes for ischemic stroke, intracerebral hemorrhage, and stroke not otherwise specified.
Primary outcome was all-cause cumulative mortality in 30-day survivors at end of follow-up, stratified by age, sex, and stroke subtype, and compared with all-cause cumulative mortality in the general population.
The study population included 15 527 patients with stroke (median age, 44 years [interquartile range, 38-47 years]; 53.3% women). At end of follow-up, a total of 3540 cumulative deaths had occurred, including 1776 deaths within 30 days after stroke and 1764 deaths (23.2%) during a median duration of follow-up of 9.3 years (interquartile range, 5.9-13.1 years). The 15-year mortality in 30-day survivors was 17.0% (95% CI, 16.2%-17.9%). The standardized mortality rate compared with the general population was 5.1 (95% CI, 4.7-5.4) for ischemic stroke (observed mortality rate 12.0/1000 person-years [95% CI, 11.2-12.9/1000 person-years]; expected rate, 2.4/1000 person-years; excess rate, 9.6/1000 person-years) and the standardized mortality rate for intracerebral hemorrhage was 8.4 (95% CI, 7.4-9.3; observed rate, 18.7/1000 person-years [95% CI, 16.7-21.0/1000 person-years]; expected rate, 2.2/1000 person-years; excess rate, 16.4/1000 person-years).
Among young adults aged 18 to 49 years in the Netherlands who were 30-day survivors of first stroke, mortality risk compared with the general population remained elevated up to 15 years later.
中风仍然是全球第二大致死原因。大约 10%至 15%的中风发生在年轻人中。专门针对年轻人的预后和死亡率的信息有限。
根据年龄、性别和中风类型,确定年轻成年人中风后短期和长期的死亡风险;死亡率的时间趋势;以及死亡原因。
设计、地点和参与者:这是一项在荷兰进行的基于登记和人群的研究,纳入了 1998 年至 2010 年间年龄在 18 至 49 岁的首次中风的 15527 例患者,随访至 2017 年 1 月 1 日。通过国家住院患者登记处、国家死因登记处和荷兰人口登记处的链接,确定患者和结局。
年龄在 18 至 49 岁的首次中风,使用国际疾病分类,第九修订版和国际疾病、损伤和死因分类,第十修订版的缺血性中风、颅内出血和未特指的中风的代码进行记录。
主要结局是所有原因的 30 天幸存者在随访结束时的累积死亡率,按年龄、性别和中风类型分层,并与一般人群的所有原因的累积死亡率进行比较。
研究人群包括 15527 例中风患者(中位年龄为 44 岁[四分位间距,38-47 岁];53.3%为女性)。在随访结束时,共发生 3540 例累积死亡,其中 1776 例死亡发生在中风后 30 天内,1764 例(23.2%)发生在中位随访 9.3 年(四分位间距,5.9-13.1 年)期间。30 天幸存者的 15 年死亡率为 17.0%(95%CI,16.2%-17.9%)。与一般人群相比,缺血性中风的标准化死亡率为 5.1(95%CI,4.7-5.4)(观察死亡率为 12.0/1000人年[95%CI,11.2-12.9/1000 人年];预期率为 2.4/1000 人年;超额率为 9.6/1000 人年),颅内出血的标准化死亡率为 8.4(95%CI,7.4-9.3;观察率为 18.7/1000 人年[95%CI,16.7-21.0/1000 人年];预期率为 2.2/1000 人年;超额率为 16.4/1000 人年)。
在荷兰年龄在 18 至 49 岁的首次中风 30 天幸存者中,与一般人群相比,死亡率风险在 15 年后仍居高不下。